Minimal UV exposure as little as 10-15 minutes of incidental sunlight accelerates results significantly
Abstract Introduction Semaglutide, the only glucagon-like peptide-1 receptor agonist (GLP-1 RA) available in subcutaneous and oral formulation for treatment of type 2 diabetes (T2D), has demonstrated clinically significant improvements in glycaemic control and weight in clinical trials
If you notice changes in the medication appearance, consistency, or effectiveness between refills, report this to your IVIM provider immediately
If youre looking for more healthy dishes to enjoy while taking medications like Ozempic, Wegovy, Mounjaro, or Zepbound, check out our blog on 9 GLP-1 Meal Ideas
Practical Considerations Primary care clinicians tend to have more individual patient contact compared with other healthcare professionals, and thereby are well placed to initiate GLP-1 RAs and facilitate long-term adherence and persistence with these therapies
No you should not accelerate the titration schedule without clinical guidance, as doing so significantly increases the risk of gastrointestinal side effects